Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10)

Name: Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10)
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

The purpose of this Notice of Amendment is to notify about the additions of: Elexacaftor, Inclisiran, Ospemifene, Pralsetinib and Tafasitamab to the Prescription Drug List (PDL) for human and veterinary use, and Frunevetmab to the PDL for veterinary use.